Blood Group Typing Market Size, Share, Trends & Forecast
The Blood Group Typing Market is expanding as blood transfusion services, hospitals, and diagnostic laboratories invest in safer and more efficient testing technologies. The market reached USD 2.41 billion in 2025 and is projected to grow from USD 2.61 billion in 2026 to USD 5.31 billion by 2035, representing a CAGR of 8.2%.
Blood group typing is essential for determining donor-recipient compatibility before transfusion and is also important in organ transplantation and certain clinical procedures. ABO blood testing accounted for 37.8% of the market in 2025, while antigen typing beyond ABO/Rh is expected to grow rapidly as healthcare providers increasingly adopt extended matching for patients requiring repeated transfusions.
Serological testing remains the foundation of routine blood classification, holding a 53.2% share in 2025. At the same time, molecular technologies such as PCR-based testing, microarrays, and next-generation sequencing are gaining attention because they can provide more detailed antigen profiles for complex transfusion cases.
North America led the market with approximately 35.5% share in 2025, supported by regulatory standards, established blood-bank infrastructure, and automation. Europe held around 28%, while Asia-Pacific is projected to record a 9.4% CAGR as blood-safety programs, hospital infrastructure, and diagnostic capacity expand across countries including India and China.
The future outlook is centered on automation, molecular genotyping, point-of-care testing, artificial intelligence-assisted interpretation, and digital blood-bank systems. Sustainable reagents and room-temperature-stable technologies may also help extend reliable blood typing services into regions where cold-chain and infrastructure limitations remain significant.
Gain a competitive edge with insightful market reports:
Ranitidine Market Distribution